Drug profile · INN
ganirelix
ARX GANIRELIX
ganirelix (ARX GANIRELIX) is a gonadotropin-releasing hormone receptor antagonist. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved NMPA: clinical trials Systemic hormonal preparations (H01) H01CC01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ganirelix
- Class
- Systemic hormonal preparations (H01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
ganirelix (ARX GANIRELIX) is a gonadotropin-releasing hormone receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN ganirelix
Brand ARX GANIRELIX
Mechanism Gonadotropin-releasing hormone receptor antagonist
Target Gonadotropin-releasing hormone receptor
Therapeutic class Systemic hormonal preparations (H01)
ATC code H01CC01
Originator Alphapharm Pty Ltd
Mechanism of action
Gonadotropin-releasing hormone receptor antagonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Related & competitor drugs
Frequently asked questions
What is ganirelix?
ganirelix (ARX GANIRELIX) is a gonadotropin-releasing hormone receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for ganirelix?
ARX GANIRELIX is a marketed brand name for ganirelix. Check FDA Drugs@FDA for the current US label holder and prescribing information.